| Wall Street Journal. Europe 1999 Elyse Tanouye |
| Title | Subject | Authors |
|---|
| Glaxo to announce discovery of genes behind three diseases; breakthroughs in migraine, psoriasis, diabetes meant to shake up industry; Dr. Roses points the way.(Glaxo Wellcome PLC and Dr. Allen Roses) | Business, international | Michael Waldholz, Elyse Tanouye |
| Novartis comes to rescue of neurotic dogs.(Abstract) | Business, international | Elyse Tanouye |
| Potent brew: blending of AHP and Warner-Lambert signals deals ahead; European drug companies are seen following path of $70 billion transaction; stocking empty cupboards.(American Home Products, includes related article)(Statistical Data Included) | Business, international | Gardiner Harris, Nikhil Deogun, Steven Lipin, Robert Langreth, Michael Waldholz, Elyse Tanouye |
| SmithKline abandons expansion efforts by selling 2 units, shuffling executives.(Abstract) | Business, international | Stephen D. Moore, Elyse Tanouye |
| SmithKline Beecham is in talks to sell its DPS Pharmacy unit for possible loss.(Abstract) | Business, international | Stephen D. Moore, Elyse Tanouye |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
